Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Vasculitis
ADR ID BADD_A04537
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.02      Vasculitides
10.02.02.006      Vasculitis
24      Vascular disorders
24.12      Vascular infections and inflammations
24.12.04      Vasculitides NEC
24.12.04.027      Vasculitis
Description A disorder characterized by inflammation involving the wall of a vessel. [CTCAE] Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. [MeSH]
MedDRA Code 10047115
MeSH ID D014657
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Angiitis | Digital vasculitis | Focal vasculitis | Panagiitis | Polyangiitis | Vasculitis | Vasculitis aggravated | Vasculitis legs | Vasculitis NOS | Vasculitis NOS aggravated | Vasculitis worsened | Granulomatous vasculitis | Ischaemic vasculitis | Ischemic vasculitis | Vasculitides | Angiitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02344Vemurafenib0.000660%
BADD_D02348Verapamil--
BADD_D02349Verapamil hydrochloride--
BADD_D02362Vinflunine--
BADD_D02367Voltaren--
BADD_D02370Vorinostat--
BADD_D02373Warfarin--
BADD_D02374Warfarin sodium--
BADD_D02375Water--
BADD_D02377Zafirlukast--
BADD_D02383Zidovudine--
BADD_D02392Zoledronic acid0.004294%
BADD_D02407Upadacitinib0.000530%
BADD_D02463Pitavastatin0.000907%
BADD_D02464Fingolimod0.000844%
BADD_D02470Nintedanib0.000302%
BADD_D02530Avacopan0.000530%
BADD_D02537Cabotegravir0.000282%
BADD_D02588Remdesivir0.000565%
The 10th Page    First    Pre   10    Total 10 Pages
ADReCS-Target
ADR Term Drug Name Target